D. J. Hong

发表

Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease.

P. Greenberg, E. Petersdorf, R. Ambinder, 1997, Blood.

CD8+ T Cell Tolerance to a Tumor-associated Antigen Is Maintained at the Level of Expansion Rather than Effector Function

M. Kalos, P. Greenberg, B. Carson, 2002, The Journal of experimental medicine.

Antigen Immunotherapy of Tumors Expressing the T Cells or CTL + High-Affinity CD8 Peripheral Tissue Does Not Preclude Recovery of Expression of a Tolerizing Tumor Antigen in

M. Kalos, P. Greenberg, D. J. Hong, 2011 .

Expression of a Tolerizing Tumor Antigen in Peripheral Tissue Does Not Preclude Recovery of High-Affinity CD8+ T Cells or CTL Immunotherapy of Tumors Expressing the Antigen1

M. Kalos, P. Greenberg, D. J. Hong, 2001, The Journal of Immunology.

the Antigen CTL Immunotherapy of Tumors Expressing T Cells or + Recovery of High-Affinity CD8 Peripheral Tissue Does Not Preclude Expression of a Tolerizing Tumor Antigen in

M. Kalos, P. Greenberg, D. J. Hong, 2001 .

Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives.

Richard E. White, J. Rivier, P. Conn, 2007, Journal of Medicinal Chemistry.

Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.

J. Rivier, C. Rivier, J. Gulyás, 2005, Journal of medicinal chemistry.

Novel analogues of degarelix incorporating hydroxy-, methoxy-, and pegylated-urea moieties at positions 3, 5, 6 and the N-terminus. Part III.

J. Rivier, C. Rivier, D. J. Hong, 2006, Journal of medicinal chemistry.

Novel gonadotropin‐releasing hormone antagonists with substitutions at position 5

J. Rivier, C. Rivier, D. J. Hong, 2005, Biopolymers.

Six novel gonadotropin-releasing hormones are encoded as triplets on each of two genes in the protochordate, Ciona intestinalis.

G. Mackie, W. Vale, J. Rivier, 2003, Endocrinology.

Synthesis and biological activity of GnRH antagonists modified at position 3 with 3-(2-methoxy-5-pyridyl)-alanine.

J. Rivier, C. Rivier, S. Koerber, 2008, The journal of peptide research : official journal of the American Peptide Society.